MiR‐138 inhibits cell proliferation and reverses epithelial‐mesenchymal transition in non‐small cell lung cancer cells by targeting <scp>GIT</scp>1 and <scp>SEMA</scp>4C

Abstract excerpt

Non-small-cell lung cancer (NSCLC) is one of the most common and lethal malignant tumours worldwide with a poor 5-year survival rate. Recent studies indicated that miRNAs have been involved in the tumorigenic driver pathways in NSCLC, but the relevant molecular mechanisms are not well-understood. In this study, we investigated the biological functions and molecular mechanisms of miR-138 in human NSCLC. The...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Axon Guidance and Neuronal Signaling
• Share to Cancer Mechanisms and Therapy
• Share to FOXO transcription factor regulation